March is Colon Cancer Awareness Month. It’s a good time to learn more about hereditary colon cancer and how to lower the risk of developing cancer. Hereditary colon cancer accounts for about 5 to 10 percent of all colon cancer cases and is caused by a genetic mutation that is inherited from either parent. Know…
Continue Reading
I never had a chance to meet my paternal grandfather, Eric. He was a handsome truck driver just like my Dad. In 1950, Eric had surgery to remove colon cancer at age 39. The operation went well and he was able to return to work. But the cancer returned eight years later and he lost…
Continue Reading
To date Myriadians across the country have successfully walked, fundraised and educated colon, ovarian, and breast cancer survivors and caregivers in 7 NOCC Walks to Break the Silence on Ovarian Cancer, 1 Colon Cancer Alliance (CCA) Undy 5000 and 1 Bright Pink FabFest. For all nine events a total of $10,680 has been raised…
Continue Reading This past September Team Myriad joined more than 500 women for Bright Pink’s annual health and wellness event, FabFest 2013. The event was co-hosted by Giuliana Rancic and Lindsey Avner, and led by Chicago’s top fitness professionals. This action-packed day pushed individuals to challenge themselves physically and inspired everyone to make lifestyle changes to proactively…
Continue Reading October is Breast Cancer Awareness Month and once again Myriad Genetics, Inc. is proud to be joining efforts with the American Cancer Society to support Making Strides against Breast Cancer. Mark your calendar and join us at this year’s Making Strides Against Breast Cancer Walk scheduled for Saturday October 12, 2013 from 8:00am to 1:00pm…
Continue Reading Not many of us can look at a genetic code and be inspired to create artwork from it. For most people a DNA sequence looks like a jumble of letters, wavelengths and bright colors. Max Nanis, however, is not “most people.” Max has married his artistic and scientific backgrounds into a project that he is…
Continue Reading Today, May 8th 2013 marks the very first World Ovarian Cancer Day. Today several organizations from around the world will join forces to raise awareness about ovarian cancer and to help educate the public about its symptoms. Approximately 11-15% of ovarian cancer cases are caused by mutations in the BRCA1 or BRCA2 genes. When someone…
Continue Reading (you can also view Jill’s video HERE) My name is Jill and I am a two-time cancer survivor—I was diagnosed with colon cancer at age 30 and endometrial cancer at age 40. My family has dealt with cancer for five generations, including three deaths from cancer. It was a mystery in my family as to…
Continue Reading “When I was in high school, my mom was diagnosed with breast cancer at age 42. She had a lumpectomy, chemo, and radiation. Every year since then, I would get that twinge of nervousness when she had her yearly mammogram…but the more years that went on, it would get a little easier because I had…
Continue Reading As the shortest month of the year draws to a close, it’s important to remember that it takes longer than 28 days to prevent the impact of cancer on your life and the lives of your loved ones. There are several life habits you can practice to improve your health and reduce your risk of…
Continue Reading February 6, 2013 RE: COLARIS® and COLARIS AP® MYH Enhancements Myriad Genetic Laboratories, Inc. is pleased to announce enhancements to our COLARIS® and COLARIS AP® testing for Lynch syndrome and Polyposis syndromes. These important enhancements demonstrate our ongoing commitment to providing the most accurate and complete testing services possible for common hereditary cancer syndromes. COLARIS…
Continue Reading Adam A. Ofer, MD, is a board-certified Ob/Gyn and the Director of Gynecology at the Norwalk Hospital in Connecticut. His focus is in urogynecology and minimally-invasive surgery, including da Vinci surgery (a minimally invasive alternative to both open surgery and laparoscopy). We are very lucky to have Dr. Ofer as one of our healthcare…
Continue Reading There are limited recommendations on this topic.1 The following summarizes the literature, however, a clinician’s judgment will also be based on the patient’s age, co-morbidities and individual circumstances. Management after risk-reducing mastectomy Prophylactic mastectomy reduces the risk of breast cancer in BRCA carriers by about 90%,2
Continue Reading It’s that time of year again! We want to remind you that during all of these family holiday gatherings it is a great time to talk to your family members about your family’s medical history. Knowing this information about your family is very important for making informed decisions about your own healthcare. It is important…
Continue Reading In the last weeks, Myriad Genetics has been conducting alumni speaker trainings for its front-line healthcare professional and mid-level providers. These providers have previously worked with Myriad to speak with their peers in a variety of settings, from presentations to a large number of providers at sponsored events, at medical society meetings and meeting one…
Continue Reading Myriad is excited to announce the launch of the online Hereditary Cancer Quiz. This quiz was designed for the general public as an easy to use, online quiz that can help determine if you are a candidate for hereditary cancer testing. The intent of the quiz is to not only to see if you are…
Continue Reading On Sunday, October 21, 2012 Dr. Matthew McKinley spoke about the importance of hereditary colorectal cancer at the American College of Gastroenterology’s Annual Scientific Meeting in Las Vegas, Nevada. Myriad employees were on-site after the presentation and took questions about how testing for hereditary colon cancer plays a key role in the treatment of those…
Continue Reading On September 28th, 2012 Myriad partnered with Living Beyond Breast Cancer (LBBC) to educate breast cancer survivors at the Annual LBBC Conference about Hereditary Breast and Ovarian Cancer syndrome. In a very casual setting atop the 33rd floor of the Loews Hotel in downtown Philadelphia, Cynthia Kimball – patient advocate and breast cancer survivor and Jill…
Continue Reading Today was an inspirational day here at Myriad. We had two amazing speakers on hand to discuss their organizations, David Barley, CEO of National Ovarian Cancer Coalition, (NOCC) as well as a representative from Bright Pink. It was very powerful to hear about all the amazing advocacy work each organization is doing. (Pictured Above: David Barley,…
Continue Reading September 26, 2012 is National Previvor Day. At Myriad, we believe knowledge is power, and Previvors embody this sentiment. A Previvor refers to an individual who carries a strong predisposition to cancer but has not developed cancer. These individuals proactively sought out knowledge to determine if they inherited a gene mutation by having genetic testing…
Continue Reading